Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program 70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to bending the obesity curve in the US: excessive US prices of medication, medication side effects, and sustainable lifestyle change NEW YORK, Aug
Ozempic works through different mechanisms in the body to: Regulate blood sugar levels by increasing insulin release (when blood glucose is high) Reduce appetite and food intake Slow gastric emptying (digestion) helps you feel full longer after meals Improve insulin sensitivity over time for better glucose control in people with type 2 diabetes While results may vary, these effects may lead to weight loss in some patients
GIP Receptor Activation (The Secret Sauce) The glucose-dependent insulinotropic peptide (GIP) pathway was dormant in older therapies but crucial for retatrutide's superiority: Metabolic Rate Increase : GIP activation increases energy expenditure by ~5-10% Fat Oxidation : Preferentially targets visceral and hepatic fat Muscle Preservation : Better maintains lean mass during weight loss Lipid Metabolism : Improves triglycerides and cholesterol profiles This is where retatrutide differs fundamentally from tirzepatide
Appetite suppression, improved insulin sensitivity, slowed gastric emptying